SomaLogic merger overcomes investor objections to win shareholder approval
SomaLogic Inc. (Nasdaq: SLGC) said Thursday evening that its $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB) is expected to be finalized Friday after shareholders for the Boulder biotech company voted this week to consummate the combination.